2 unknown. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Unknown 2 |
Follow Dermatomyositis, Adult Type: new trials by email Literature Review of Dermatomyositis, Adult Type trials Research Report on Dermatomyositis, Adult Type
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of Triple Therapy in Patients With Anti-MDA5 Antibody-positive Dermatomyositis triple therapy, dual-therapy - Dermatomyositis, Adult Type, Interstitial Lung Disease | Phase 4 | Unknown | The First Affiliated Hospital with Nanjing Medical University | 120 | 2022-01-01 | 2022-05-26 |
| The Efficacy and Safety of JAK Inhibitor in the Treatment of Anti-MDA5 Antibody-positive Dermatomyositis Patients JAK Inhibitor - Dermatomyositis, Adult Type | Phase 4 | Unknown | First Affiliated Hospital Xi'an Jiaotong University | 20 | 2020-04-02 | 2021-07-19 |
Dermatomyositis (2) · Lung Diseases, Interstitial (1)
Connective Tissue Diseases (2) · Muscular Diseases (2) · Musculoskeletal Diseases (2) · Myositis (2) · Nervous System Diseases (2) · Neuromuscular Diseases (2) · Polymyositis (2) · Skin Diseases (2) · Skin and Connective Tissue Diseases (2) · Lung Diseases (1) · Respiratory Tract Diseases (1)
Dual Anti-Platelet Therapy (1) · Janus Kinase Inhibitors (1)
First Affiliated Hospital Xi'an Jiaotong University (1) · The First Affiliated Hospital with Nanjing Medical University (1)
China (2)
Lan He (1)